These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23754463)

  • 21. [Certified prostate centers of the DVPZ : Current status].
    Zumbe J; Berges R
    Urologe A; 2010 Aug; 49(8):916-21. PubMed ID: 20652675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NICE guidelines on Prostate Cancer Active Surveillance: is UK practice leading the world?
    Streeter EH; Brewster SF;
    BJU Int; 2015 Jan; 115(1):12-3. PubMed ID: 24684414
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer.
    Onukwugha E; Mullins CD; Hsu VD; Seal B; Hussain A
    Urology; 2011 May; 77(5):1088-95. PubMed ID: 21439617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Specialist uro-oncological rehabilitation after treatment for prostate cancer--update 2015. Position statement of the working group on "rehabilitation of urological and nephrological diseases" of the German Society of Urology with respect to current S3 guidelines].
    Müller G; Otto U; Vahlensieck W; Zermann DH
    Urologe A; 2015 Aug; 54(8):1108-14. PubMed ID: 26246209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACR Appropriateness Criteria® posttreatment follow-up of prostate cancer.
    Casalino DD; Remer EM; Arellano RS; Bishoff JT; Coursey CA; Dighe M; Eggli DF; Fulgham P; Israel GM; Lazarus E; Leyendecker JR; Nikolaidis P; Papanicolaou N; Prasad S; Ramchandani P; Sheth S; Vikram R
    J Am Coll Radiol; 2011 Dec; 8(12):863-71. PubMed ID: 22137005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined chemohormonal therapy for metastatic hormone-sensitive prostate cancer : Effectiveness and update as a joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].
    Ohlmann CH; Gschwend J; Miller K;
    Urologe A; 2015 Nov; 54(11):1606-8. PubMed ID: 26385244
    [No Abstract]   [Full Text] [Related]  

  • 27. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization.
    de Graaf P; Göricke S; Rodjan F; Galluzzi P; Maeder P; Castelijns JA; Brisse HJ;
    Pediatr Radiol; 2012 Jan; 42(1):2-14. PubMed ID: 21850471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Documentation of the Governing Body of Prostate Centers (DVPZ)].
    Brehmer B; Berges R; Ebert T; Goepel M; Heidenreich A
    Urologe A; 2013 Mar; 52(3):408-13. PubMed ID: 23429882
    [No Abstract]   [Full Text] [Related]  

  • 29. How are we going to train a generation of radiologists (and urologists) to read prostate MRI?
    Puech P; Randazzo M; Ouzzane A; Gaillard V; Rastinehad A; Lemaitre L; Villers A
    Curr Opin Urol; 2015 Nov; 25(6):522-35. PubMed ID: 26375060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer.
    Lam TBL; MacLennan S; Plass K; Willemse PM; Mason MD; Cornford P; Donaldson J; Davis NF; Dell'Oglio P; Fankhauser C; Grivas N; Ingels A; Lardas M; Liew M; Pang KH; Paterson C; Omar MI; Zattoni F; Buddingh KT; Van den Broeck T; Cumberbatch MG; Fossati N; Gross T; Moris L; Schoots IG; van den Bergh RCN; Briers E; Fanti S; De Santis M; Gillessen S; Grummet JP; Henry AM; van der Poel HG; van der Kwast TH; Rouvière O; Tilki D; Wiegel T; N'Dow J; Van Poppel H; Mottet N
    Eur Urol; 2019 Apr; 75(4):699-702. PubMed ID: 30473433
    [No Abstract]   [Full Text] [Related]  

  • 31. [Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].
    Ohlmann CH; Miller K; Gschwend J
    Urologe A; 2017 Sep; 56(9):1185-1186. PubMed ID: 28733874
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy.
    Lim CS; McInnes MDF; Lim RS; Breau RH; Flood TA; Krishna S; Morash C; Shabana WM; Schieda N
    J Magn Reson Imaging; 2017 Jul; 46(1):257-266. PubMed ID: 27807914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; van den Bergh RCN; Briers E; Van den Broeck T; Cumberbatch MG; De Santis M; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Grummet J; Henry AM; van der Kwast TH; Lam TB; Lardas M; Liew M; Mason MD; Moris L; Oprea-Lager DE; van der Poel HG; Rouvière O; Schoots IG; Tilki D; Wiegel T; Willemse PM; Cornford P
    Eur Urol; 2021 Feb; 79(2):243-262. PubMed ID: 33172724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrepancies in the Recommended Management of Adrenal Incidentalomas by Various Guidelines.
    Maas M; Nassiri N; Bhanvadia S; Carmichael JD; Duddalwar V; Daneshmand S
    J Urol; 2021 Jan; 205(1):52-59. PubMed ID: 32856984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A urologists' guide to the multi-parametric magnetic resonance imaging (mpMRI)-galaxy.
    Kastner C
    BJU Int; 2015 Apr; 115(4):503-4. PubMed ID: 25808711
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Axel Heidenreich. Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol 2011;59:495-7.
    Barentsz J; Dickinson L; Sciarra A
    Eur Urol; 2011 Jul; 60(1):e5-6. PubMed ID: 21429656
    [No Abstract]   [Full Text] [Related]  

  • 37. [Certified prostate cancer centers of the German Cancer Society : Current status 2 years after certification and future developments].
    Steffens JA; Ting O; Schmidt S; Albers P
    Urologe A; 2010 Aug; 49(8):910-5. PubMed ID: 20628869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance.
    Eberhardt SC; Carter S; Casalino DD; Merrick G; Frank SJ; Gottschalk AR; Leyendecker JR; Nguyen PL; Oto A; Porter C; Remer EM; Rosenthal SA
    J Am Coll Radiol; 2013 Feb; 10(2):83-92. PubMed ID: 23374687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer early detection. Clinical practice guidelines in oncology.
    Kawachi MH; Bahnson RR; Barry M; Carroll PR; Carter HB; Catalona WJ; Epstein JI; Etzioni RB; Hemstreet GP; Howe RJ; Kopin JD; Lange PH; Lilja H; Mohler J; Moul J; Nadler RB; Patterson S; Pollack A; Presti JC; Stroup AM; Urban DA; Wake R; Wei JT;
    J Natl Compr Canc Netw; 2007 Aug; 5(7):714-36. PubMed ID: 17692177
    [No Abstract]   [Full Text] [Related]  

  • 40. [PI-RADS classification: structured reporting for MRI of the prostate].
    Röthke M; Blondin D; Schlemmer HP; Franiel T
    Rofo; 2013 Mar; 185(3):253-61. PubMed ID: 23404430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.